Examen Ltd

Back to portfolio

In vitro diagnostics company specialising in male infertility and miscarriage testing.

Examen is a diagnostics company. Our mission is to transform the diagnosis and treatment of male reproductive problems. 

Examen was set up in response to public demand for our market–leading sperm DNA fragmentation test, the SpermComet®. SpermComet® was developed following more than twenty years of research into better tests for male infertility and treatment. Now we can provide accurate information for male fertility diagnosis and better prediction of fertility treatment success. The founder of Examen is internationally acclaimed academic in male fertility; Professor Sheena Lewis FRSB.

Key Facts

  • We provide a unique, accurate molecular test that checks out the quality of sperm DNA.
  • High sperm DNA damage causes male infertility
  • High sperm DNA damage leads to poor fertility treatment success
  • High sperm DNA damage causes miscarriage
  • Having the test gives couples new options and saves them time, money and heartbreak
    Visit website
    • Life Science

      Phion Therapeutics Ltd

      pHion has created a simple & self–assembling drug delivery system that is easy to use, cost effective and maximises nucleic acid bioavailability.

      Read more
    • Life Science

      Re–Vana Therapeutics Ltd

      Re–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.

      Read more
    • Digital, Life Science

      Sonrai Analytics

      Sonrai Analytics focuses on providing a cloud–enabled bespoke knowledge platform to conduct modern–day analytics for ‘big data’

      Read more
    • Life Science

      CV6 Therapeutics (NI) Ltd

      CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.

      Read more